Regulatory mechanisms in the differential expression of Hemokinin-1

Neuropeptides

Volumn 43, Issue 1, 2009, Pages 1-12

  Tran, Anne H ^a   Berger, Alexandra ^a   Wu, Gillian E ^b   Paige, Christopher J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b YORK UNIVERSITY   (Canada)

Author keywords

CREB; Hemokinin 1; Immune cells; NF B; Promoter; Substance P; TAC1; TAC4; Tachykinin; Transcription regulation

Indexed keywords

HEMOKININ 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; SUBSTANCE P; TACHYKININ DERIVATIVE; TATA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINE; CELL TYPE; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CARCINOGENS; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FORSKOLIN; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RATS; SUBSTANCE P; TACHYKININS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC;

EID: 59349092003     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2008.10.002     Document Type: Article

References (59)

1. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12 (1994) 141-179
2. Berger A., and Paige C.J. Hemokinin-1 has substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study. J. Neuroimmunol. 164 (2005) 48-56
3. Berger A., Tran A.H., and Paige C.J. Co-regulated decrease of Neurokinin-1 receptor and Hemokinin-1 gene expression in monocytes and macrophages after activation with pro-inflammatory cytokines. J. Neuroimmunol. 187 (2007) 83-93
4. Calin-Jageman I.E., Wang J., and Bannon M.J. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism. J. Neurochem. 97 (2006) 255-264
5. Camarda V., Rizzi A., Calo G., Guerrini R., Salvadori S., and Regoli D. Pharmacological profile of Hemokinin 1: a novel member of the tachykinin family. Life Sci. 71 (2002) 363-370
6. Carter M.S., and Krause J.E. Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma. J. Neurosci. 10 (1990) 2203-2214
7. Corcoran K.E., and Rameshwar P. Nuclear factor-kappaB accounts for the repressor effects of high stromal cell-derived factor-1alpha levels on Tac1 expression in nontumorigenic breast cells. Mol. Cancer Res. 5 (2007) 373-381
8. Coulson J.M., Ahmed S.I., Quinn J.P., and Woll P.J. Detection of small cell lung cancer by RT-PCR for neuropeptides, neuropeptide receptors, or a splice variant of the neuron restrictive silencer factor. Meth. Mol. Med. 75 (2003) 335-352
9. Duffy R.A., Hedrick J.A., Randolph G., Morgan C.A., Cohen-Williams M.E., Vassileva G., Lachowicz J.E., Laverty M., Maguire M., Shan L.S., Gustafson E., and Varty G.B. Centrally administered Hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. Neuropharmacology 45 (2003) 242-250
10. Endo D., Ikeda T., Ishida Y., Yoshioka D., and Nishimori T. Effect of intrathecal administration of Hemokinin-1 on the withdrawal response to noxious thermal stimulation of the rat hind paw. Neurosci. Lett. 392 (2006) 114-117
11. Fiskerstrand C., and Quinn J.P. The molecular biology of preprotachykinin-A gene expression. Neuropeptides 30 (1996) 602-610
12. Fiskerstrand C.E., Newey P., Ebrahimi B., Gerrard L., Harrison P., McGregor G.P., and Quinn J.P. Novel cell lines for the analysis of preprotachykinin A gene expression identify a repressor domain 3′ of the major transcriptional start site. Biochem. J. 341 Pt 3 (1999) 847-852
13. Fiskerstrand C.E., Newey P., McGregor G.P., Gerrard L., Millan F., and Quinn J.P. A role for octamer binding protein motifs in the regulation of the proximal preprotachykinin-A promoter. Neuropeptides 34 (2000) 348-354
14. Fiskerstrand C.F., Newey P., Millan F., and Quinn J.P. The role of the octamer binding proteins and the NF-ΚB complex in neuropeptide gene expression. Biochem. Soc. Trans. 25 (1997) S573
15. Fu C.Y., Kong Z.Q., Wang K.R., Yang Q., Zhai K., Chen Q., and Wang R. Effects and mechanisms of supraspinal administration of rat/mouse Hemokinin-1, a mammalian tachykinin peptide, on nociception in mice. Brain Res. 1056 (2005) 51-58
16. Gerrard L., Howard M., Paterson T., Thippeswamy T., Quinn J.P., and Haddley K. A proximal E-box modulates NGF effects on rat PPT-A promoter activity in cultured dorsal root ganglia neurones. Neuropeptides 39 (2005) 475-483
17. Graham G.J., Stevens J.M., Page N.M., Grant A.D., Brain S.D., Lowry P.J., and Gibbins J.M. Tachykinins regulate the function of platelets. Blood 104 (2004) 1058-1065
18. Greco S.J., Smirnov S.V., Murthy R.G., and Rameshwar P. Synergy between the RE-1 silencer of transcription and NFkappaB in the repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells. J. Biol. Chem. 282 (2007) 30039-30050
19. Harrison S., and Geppetti P. Substance p. Int. J. Biochem. Cell Biol. 33 (2001) 555-576
20. Ho W.Z., Lai J.P., Zhu X.H., Uvaydova M., and Douglas S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol. 159 (1997) 5654-5660
21. Ince T.A., and Scotto K.W. A conserved downstream element defines a new class of RNA polymerase II promoters. J. Biol. Chem. 270 (1995) 30249-30252
22. Jones S., Tucker K.L., Sage T., Kaiser W.J., Barrett N.E., Lowry P.J., Zimmer A., Hunt S.P., Emerson M., and Gibbins J.M. Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. Blood 111 (2008) 605-612
23. Kurtz M.M., Wang R., Clements M.K., Cascieri M.A., Austin C.P., Cunningham B.R., Chicchi G.G., and Liu Q. Identification, localization and receptor characterization of novel mammalian substance P-like peptides. Gene 296 (2002) 205-212
24. Lai J.P., Douglas S.D., and Ho W.Z. Human lymphocytes express substance P and its receptor. J. Neuroimmunol. 86 (1998) 80-86
25. Lai J.P., Douglas S.D., Shaheen F., Pleasure D.E., and Ho W.Z. Quantification of substance p mRNA in human immune cells by real-time reverse transcriptase PCR assay. Clin. Diagn. Lab. Immunol. 9 (2002) 138-143
26. Lambrecht B.N., Germonpre P.R., Everaert E.G., Carro-Muino I., De Veerman M., de Felipe C., Hunt S.P., Thielemans K., Joos G.F., and Pauwels R.A. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur. J. Immunol. 29 (1999) 3815-3825
27. Lin Y., Ince T.A., and Scotto K.W. Optimization of a versatile in vitro transcription assay for the expression of multiple start site TATA-less promoters. Biochemistry 40 (2001) 12959-12966
28. Longmore J., Hill R.G., and Hargreaves R.J. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs. Can. J. Physiol. Pharmacol. 75 (1997) 612-621
29. MacKenzie A., Payne C., Boyle S., Clarke A.R., and Quinn J.P. The human preprotachykinin-A gene promoter has been highly conserved and can drive human-like marker gene expression in the adult mouse CNS. Mol. Cell Neurosci. 16 (2000) 620-630
30. Maggi C.A. The effects of tachykinins on inflammatory and immune cells. Regul. Pept. 70 (1997) 75-90
31. Mendelson S.C., Fiskerstrand C.E., and Quinn J.P. A role for the octamer-binding protein in preprotachykinin-A gene expression. Neuropeptides 32 (1998) 79-85
32. Mendelson S.C., Morrison C.F., McAllister J., Paterson J.M., Dobson S.P., Mulderry P.K., and Quinn J.P. Repression of preprotachykinin-A promoter activity is mediated by a proximal promoter element. Neuroscience 65 (1995) 837-847
33. Mendelson S.C., and Quinn J.P. Characterisation of potential regulatory elements within the rat preprotachykinin-A promoter. Neurosci. Lett. 184 (1995) 125-128
34. Metwali A., Blum A.M., Elliott D.E., Setiawan T., and Weinstock J.V. Cutting edge: Hemokinin has substance P-like function and expression in inflammation. J. Immunol. 172 (2004) 6528-6532
35. Millward-Sadler S.J., Mackenzie A., Wright M.O., Lee H.S., Elliot K., Gerrard L., Fiskerstrand C.E., Salter D.M., and Quinn J.P. Tachykinin expression in cartilage and function in human articular chondrocyte mechanotransduction. Arthritis Rheum. 48 (2003) 146-156
36. Milne C.D., Fleming H.E., Zhang Y., and Paige C.J. Mechanisms of selection mediated by interleukin-7, the preBCR, and Hemokinin-1 during B-cell development. Immunol. Rev. 197 (2004) 75-88
37. Morrison C.F., McAllister J., Dobson S.P., Mulderry P.K., and Quinn J.P. An activator element within the preprotachykinin-A promoter. Mol. Cell. Neurosci. 5 (1994) 165-175
38. Morrison C.F., McAllister J., Lyons V., Chapman K., and Quinn J.P. The rat preprotachykinin-A promoter is regulated in PC12 cells by the synergistic action of multiple stimuli. Neurosci. Lett. 181 (1994) 117-120
39. Naono R., Nakayama T., Ikeda T., Matsusima O., and Nishimori T. Pharmacological characterization of desensitization in scratching behavior induced by intrathecal administration of Hemokinin-1 in the rat. Neuropeptides 42 (2008) 47-55
40. Naono R., Yoshioka D., Ikeda T., Nakayama T., and Nishimori T. The common carboxyl-terminal region of novel tachykinin peptides contributes to induce desensitization in scratching behavior of rats. Brain. Res. Bull. 71 (2007) 461-465
41. Nelson D.A., and Bost K.L. Non-neuronal mammalian tachykinin expression. Front Biosci. 9 (2004) 2166-2176
42. Nelson D.A., Marriott I., and Bost K.L. Expression of Hemokinin 1 mRNA by murine dendritic cells. J. Neuroimmunol. 155 (2004) 94-102
43. Page N.M. Hemokinins and endokinins. Cell. Mol. Life Sci. 61 (2004) 1652-1663
44. Page N.M. Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides. Vascul. Pharmacol. 45 (2006) 200-208
45. Pascual D.W., McGhee J.R., Kiyono H., and Bost K.L. Neuroimmune modulation of lymphocyte function-I. Substance P enhances immunoglobulin synthesis in lipopolysaccharide activated murine splenic B cell cultures. Int. Immunol. 3 (1991) 1223-1229
46. Paterson J.M., Mendelson S.C., McAllister J., Morrison C.F., Dobson S., Grace C., and Quinn J.P. Three immediate early gene response elements in the proximal preprotachykinin-A promoter in two functionally distinct domains. Neuroscience 66 (1995) 921-932
47. Paterson J.M., Morrison C.F., Mendelson S.C., McAllister J., and Quinn J.P. An upstream stimulatory factor (USF) binding motif is critical for rat preprotachykinin-A promoter activity in PC12 cells. Biochem. J. 310 Pt 2 (1995) 401-406
48. Pernow B. Substance P - a putative mediator of antidromic vasodilation. Gen. Pharmacol. 14 (1983) 13-16
49. Qian B.F., Zhou G.Q., Hammarstrom M.L., and Danielsson A. Both substance P and its receptor are expressed in mouse intestinal T lymphocytes. Neuroendocrinology 73 (2001) 358-368
50. Quinn J.P., Bubb V.J., Marshall-Jones Z.V., and Coulson J.M. Neuron restrictive silencer factor as a modulator of neuropeptide gene expression. Regul. Pept. 108 (2002) 135-141
51. Quinn J.P., Fiskerstrand C.E., Gerrard L., MacKenzie A., and Payne C.M. Molecular models to analyse preprotachykinin-A expression and function. Neuropeptides 34 (2000) 292-302
52. Quinn J.P., McAllister J., and Mendelson S. Multiple protein complexes, including AP2 and Sp1, interact with a specific site within the rat preprotachykinin-A promoter. Biochim. Biophys. Acta 1263 (1995) 25-34
53. Quinn J.P., Mendelson S.C., Paterson J.M., McAllister J., and Morrison C.F. Transcriptional control of neuropeptide gene expression in sensory neurons, using the preprotachykinin-A gene as a model. Can. J. Physiol. Pharmacol. 73 (1995) 957-962
54. Rudge T.L., and Johnson L.F. Inactivation of MED-1 elements in the TATA-less, initiator-less mouse thymidylate synthase promoter has no effect on promoter strength or the complex pattern of transcriptional start sites. J. Cell. Biochem. 73 (1999) 90-96
55. Weinstock J.V., Blum A., Walder J., and Walder R. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J. Immunol. 141 (1988) 961-966
56. Weinstock J.V., and Blum A.M. Release of substance P by granuloma eosinophils in response to secretagogues in murine schistosomiasis mansoni. Cell. Immunol. 125 (1990) 380-385
57. Zhang Y., Berger A., Milne C.D., and Paige C.J. Tachykinins in the immune system. Curr. Drug. Targets 7 (2006) 1011-1020
58. Zhang Y., Lu L., Furlonger C., Wu G.E., and Paige C.J. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. 1 (2000) 392-397
59. Zhang Y., and Paige C.J. T-cell developmental blockage by tachykinin antagonists and the role of Hemokinin 1 in T lymphopoiesis. Blood 102 (2003) 2165-2172